MOSCOW (MRC) -- Royal DSM N.V., a Dutch Life Sciences and Materials Sciences company, reported a sharp decline in third-quarter net profit, despite strong performance in all segments, said the company in its press release.
Looking ahead, the company said its full-year 2014 outlook is in line with current market expectations. For the third quarter, net profit decreased 21% to 93 million euros from 117 million euros last year. Net earnings per share was 0.51 euros, down from 0.65 euros in the previous year.
The company noted that the prior year figures were restated for the impact of the termination of proportional consolidation for joint ventures as from 1 Jan 2014 onward. Net profit from continuing operations dropped 10% to 121 million euros or 0.69 euro per share, while core net profit, which excluded certain items, dropped 3% to 141 million euros or 0.81 euro per share.
Earnings before interest, tax, depreciation and amortization or EBITDA from continuing operations, before exceptional items, was 315 million euros, 5% lower than 331 million euros last year.
Net sales for the quarter declined 1% to 2.323 billion euros from 2.354 billion euros last year, on the absence of last year's sales from discontinued operations. On an organic basis, sales grew 5% from last year with improved results in all segments.
As MRC wrote before, Royal DSM signed a partnership agreement with long fibre thermoplastic (LFT) specialist Plasticomp (Winona, Minnesota / USA) to develop bio-based LFT composite materials based on DSM’s "EcoPaXX" polyamide 4.10. The lightweight materials, which include compounds reinforced with glass fiber as well as carbon fiber, will be targeted at automotive and other performance-driven markets.
Royal DSM is a global science-based company active in health, nutrition and materials. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials.
MRC